Why Assigning Patents To Native American Tribes To Avoid Inter Partes Review Is Bad Medicine
Here are three big reasons why, according to IP columnist Tom Kulik.
A New Patent Loophole? Paying Off A Native American Tribe To Exploit Its Sovereign Immunity
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
Managing Partners are Navigating the AI Inflection Point.
New executive research from Ari Kaplan explores how law firm leaders are responding to changing client expectations, evolving economics, talent transformation, and AI governance.